🇪🇸·5d agoRegulatory
La AEMPS retira varios productos adelgazantes por contener sibutramina, un principio activo no autorizado en la UE por sus efectos adversos graves
Publisher
A
AEMPS (Spain)
Spain
This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- AEMPS (Spain)
- Region
- Spain
- Scope
- Regulatory
- Published
- September 2, 2026
Publisher context, original article off-platform
This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.
Source route
Continue on aemps.gob.es
Leave the platform to read the original full article on the publisher site.
Source: AEMPS (Spain)
Scope: Regulatory
Related coverage
More related coverage
UFRJ Brazil/2d ago
UFRJ lamenta a morte do professor emérito Carlos Russo
drugscontrol.org/2d ago
FDA Recasts Drug Packaging Oversight with Science- and Risk-Based Container Closure Guidance
AD HOC NEWS/2d ago
ORIC stock holds steady as biotech eyes next trial and earnings
timothysykes.com/2d ago